Terms: = Prostate cancer AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Prognosis
12 results:
1. Primary mucinous adenocarcinoma of the urethra: A contemporary clinicopathologic analysis of 17 patients.
Alrohaibani A; Osunkoya AO
Pathol Res Pract; 2024 Apr; 256():155273. PubMed ID: 38565023
[TBL] [Abstract] [Full Text] [Related]
2. [The impact of VDR gene polymorphisms on obesity, metabolic changes, bone mass disorders and neoplastic processes].
Wysoczańska-Klaczyńska A; Ślęzak A; Hetman M; Barg E
Pediatr Endocrinol Diabetes Metab; 2018; 24(2):96-105. PubMed ID: 30300431
[TBL] [Abstract] [Full Text] [Related]
3. Sigmoid Colon Adenocarcinoma with Isolated Loss of PMS2 Presenting in a Patient with Synchronous prostate cancer with Intact MMR: Diagnosis and Analysis of the Family Pedigree.
Liu W; Zhang D; Tan SA; Liu X; Lai J
Anticancer Res; 2018 Aug; 38(8):4847-4852. PubMed ID: 30061258
[TBL] [Abstract] [Full Text] [Related]
4. Alternative Polyadenylation Patterns for Novel Gene Discovery and Classification in cancer.
Begik O; Oyken M; Cinkilli Alican T; Can T; Erson-Bensan AE
Neoplasia; 2017 Jul; 19(7):574-582. PubMed ID: 28624626
[TBL] [Abstract] [Full Text] [Related]
5. Accuracy of preoperative multiparametric magnetic resonance imaging for prediction of unfavorable pathology in patients with localized prostate cancer undergoing radical prostatectomy.
Lee H; Kim CK; Park BK; Sung HH; Han DH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
World J Urol; 2017 Jun; 35(6):929-934. PubMed ID: 27738805
[TBL] [Abstract] [Full Text] [Related]
6. [Urothelial-type mucinous adenocarcinoma of the prostate: A case report and review of the literature].
Guo YS; Gao SM; Zhang MR; Zhang JM; Zang YJ; Lu HK
Zhonghua Nan Ke Xue; 2016 Mar; 22(3):241-5. PubMed ID: 27172665
[TBL] [Abstract] [Full Text] [Related]
7. Identifying cancer origin using circulating tumor cells.
Lu SH; Tsai WS; Chang YH; Chou TY; Pang ST; Lin PH; Tsai CM; Chang YC
Cancer Biol Ther; 2016 Apr; 17(4):430-8. PubMed ID: 26828696
[TBL] [Abstract] [Full Text] [Related]
8. The role of immunohistochemistry in discriminating primary from secondary extramammary Paget disease.
Perrotto J; Abbott JJ; Ceilley RI; Ahmed I
Am J Dermatopathol; 2010 Apr; 32(2):137-43. PubMed ID: 20051815
[TBL] [Abstract] [Full Text] [Related]
9. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature.
Köstner K; Denzer N; Müller CS; Klein R; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3511-36. PubMed ID: 19667145
[TBL] [Abstract] [Full Text] [Related]
10. Prostatic adenocarcinoma in colorectal biopsy: clinical and pathologic features.
Lane Z; Epstein JI; Ayub S; Netto GJ
Hum Pathol; 2008 Apr; 39(4):543-9. PubMed ID: 18234278
[TBL] [Abstract] [Full Text] [Related]
11. Distinguishing prostatic from colorectal adenocarcinoma on biopsy samples: the role of morphology and immunohistochemistry.
Owens CL; Epstein JI; Netto GJ
Arch Pathol Lab Med; 2007 Apr; 131(4):599-603. PubMed ID: 17425391
[TBL] [Abstract] [Full Text] [Related]
12. Expression of the intestinal marker cdx2 in secondary adenocarcinomas of the colorectum.
Groisman GM; Bernheim J; Halpern M; Brazowsky E; Meir A
Arch Pathol Lab Med; 2005 Jul; 129(7):920-3. PubMed ID: 15974817
[TBL] [Abstract] [Full Text] [Related]
